there is a truck load of crap being put out by several posters too
in response to pts made in previous post
1. why trust cyt 'market research' over pgl/avx!?!
2. wrong, as there is a clear move for big pharma to pick up 'de-risked' assets, such as near end of phase iii after interim data release, such as ATC
3. wrong, why would long-term institutional investors, like some of those in PGL, suddenly want to bail if there were more sp gains ahead
4. wrong, phase iii interim data is about to come out, with info about dosing and a key de-risking of ATC. The AVX ceo payment has been around, written in stone for some time and is for past and current performance, so wrong again
wrong also about the pgl directors, who only receive $60k per year a proportion of which must be taken in shares, which they can not purchase! considering the experience/ its hardly a big money spinner for them considerng some of the crap they have to put up with!
Progen shareholders should not give their vote to a company that is trying to steal their cash with no detail on the table, or there shares will be devalued in the CYT merger!
whats in it for you ousia
PGL Price at posting:
70.5¢ Sentiment: LT Buy Disclosure: Held